A recent Miami Herald article discussed the recall of a weight loss drug found to contain an illegal ingredient linked to heart attacks. The one lot of Lipodrene w/25mg Ephedra Extract Dietary Supplement contained DMAA, which is illegal to market according to the FDA. DMAA narrows blood vessels and arteries, which increases blood pressure and can cause cardiovascular problems such as shortness of breath, arrhythmias, and heart attack. Hi-Tech Pharmaceuticals, the manufacturer of the product, issued the recall notice and is investigating the issues.
Weight Loss Drug Recalled Due to Dangerous Illegal Ingredient
One lot of over-the-counter Lipodrene was recalled for containing DMAA, which can cause heart attacks.
May 20, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
